Alcami, a global pharmaceutical CDMO, has appointed Timothy Compton as Chief Business Officer. Mr. Compton brings more than 25 years of industry experience leading high-performing business teams. He will be responsible for driving the continued growth of Alcami’s service offerings.
 

Mr. Compton previously served as Chief Commercial Officer at Avid Bioservices, Inc. From 2015 to 2019, he was the Vice President of Sales and Marketing at Avista Pharma, a private equity-owned CDMO acquired by Cambrex Corp. in January 2019. Mr. Compton also served in numerous executive leadership roles at AAIPharma Services Corporation (Alcami) from 2010 to 2014.
 
“Tim’s proven track record of leading customer-focused business operations that generate significant year-over-year growth makes him the ideal executive to lead Alcami’s business operations,” said Patrick Walsh, Chairman and CEO at Alcami.
 
Mr. Compton added, “I look forward to returning to Alcami and working with the agile and experienced team that supports our customers and the patients we collectively serve.”